204 related articles for article (PubMed ID: 22531846)
1. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
[TBL] [Abstract][Full Text] [Related]
2. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
3. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.
Quan P; Xia D; Piao H; Piao H; Shi K; Jia Y; Cui F
AAPS PharmSciTech; 2011 Dec; 12(4):1136-43. PubMed ID: 21892695
[TBL] [Abstract][Full Text] [Related]
4. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
[TBL] [Abstract][Full Text] [Related]
6. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J
Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nitrendipine solid lipid nanoparticles.
Manjunath K; Venkateswarlu V; Hussain A
Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
[TBL] [Abstract][Full Text] [Related]
9. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: the critical size in improving bioavailability.
Fu Q; Kou L; Gong C; Li M; Sun J; Zhang D; Liu M; Sui X; Liu K; Wang S; He Z
Int J Pharm; 2012 May; 427(2):358-64. PubMed ID: 22370475
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
Zhang J; Lv H; Jiang K; Gao Y
Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
Manjunath K; Venkateswarlu V
J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
[TBL] [Abstract][Full Text] [Related]
16. Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates.
Li L; Liu Y; Wang J; Chen L; Zhang W; Yan X
Drug Deliv; 2016; 23(1):79-87. PubMed ID: 24786485
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
[TBL] [Abstract][Full Text] [Related]
18. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
19. Lutein nanocrystals as antioxidant formulation for oral and dermal delivery.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Nov; 420(1):141-6. PubMed ID: 21884768
[TBL] [Abstract][Full Text] [Related]
20. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
